Docking and Dynamics Study of Phytochemicals as Potent Inhibitors against SARS-CoV-2 Main Protease

Docking and Dynamics Study of Phytochemicals as Potent Inhibitors against SARS-CoV-2 Main Protease

Coronavirus Infectious Disease-19 (COVID-19) caused by coronavirus 2 is a global health hazard. The lack of medications against the disease is a major concern of the research community today. Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease (SARS-CoV-2 MPro) is the most extensively stud...

Full description

Bibliographic Details
Main Authors:	Palla Ramprasad, Arunkumar Babu, Suveena Sukumaran
Format:	Article
Language:	English
Published:	Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya 2022-12-01
Series:	Journal of Molecular Docking
Subjects:	COVID-19 SARS-CoV-2 MPro Lipinski Coruscanone
Online Access:	https://journal.umpr.ac.id/index.php/jmd/article/view/3969

Similar Items

Computational Screening of Repurposed Drugs Targeting Sars-Cov-2 Main Protease By Molecular Docking
by: Yow Hui Yin, et al.
Published: (2022-09-01)

Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking
by: Bijun Cheng, et al.
Published: (2020-08-01)

SARS-CoV-2 main protease inhibitors from the stem barks of Discoglypremna caloneura (Pax) Prain (Euphorbiaceae) and Pterocarpus erinaceus Poir (Fabaceae) and their molecular docking investigation
by: Paul Toukam Djouonzo, et al.
Published: (2023-11-01)

THE POTENTIAL OF CARRAGEENAN FOR THE DRUG DISCOVERY OF COVID-19 VIA MOLECULAR DOCKING WITH ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) AND THE MAIN PROTEASE (MPRO) OF SAR-COV-2
by: Thet, H.A.
Published: (2022-11-01)

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease
by: Qian Wang, et al.
Published: (2023-02-01)

Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
by: Katarzyna Papaj, et al.
Published: (2021-11-01)

Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis
by: Ganesh Sharma, et al.
Published: (2025-01-01)

Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitro, molecular docking and simulation analysis
by: Yousef T.M. Alharbi, et al.
Published: (2024-05-01)

In Silico Study of Secondary Metabolites in Dendrobium spp. as SARS-CoV-2 Antivirus on Main Protease (Mpro)
by: Anggiresti Kinasih, et al.
Published: (2022-03-01)

Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main protease
by: Atatreh Noor, et al.
Published: (2021-09-01)

In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate
by: Simone Di Micco, et al.
Published: (2021-01-01)

Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19
by: Karol Biernacki, et al.
Published: (2024-12-01)

Identification of Anti-HIV/Migraine Drugs as Potential Inhibitors of SARS-Cov2 Main Protease Using in Silico Assessments
by: Hanifeh Shariatifar, et al.
Published: (2022-10-01)

An in-silico investigation of potential natural polyphenols for the targeting of COVID main protease inhibitor
by: Nada H. Aljarba, et al.
Published: (2022-10-01)

Diversifying the chloroquinoline scaffold against SARS-COV-2 main protease: Virtual screening approach using cross-docking, sitemap analysis and molecular dynamics simulation
by: Aissaoui Mohamed, et al.
Published: (2023-01-01)

Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro
by: Zainab Jan, et al.
Published: (2023-01-01)

Identification of potential corticosteroid binding sites on the SARS CoV-2 main protease Mpro — in silico docking study
by: Н. В. Хміль, et al.
Published: (2024-08-01)

A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis
by: Asma Fatima, et al.
Published: (2024-09-01)

Synthesis, anti-inflammatory, molecular docking and ADME studies of new derivatives of ketoprofen as cyclooxygenases inhibitor
by: Mustafa M. Allawi, et al.
Published: (2019-12-01)

Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning
by: Karina Eurídice Juárez-Mercado, et al.
Published: (2024-02-01)

Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection
by: Rui Ge, et al.
Published: (2022-03-01)

In silico investigation of HCV and RNA synthesis inhibitor antibiotic drugs as potential inhibitors of SARS‑CoV‑2 main protease (Mpro)
by: Merusomayajula V. Kishore, et al.
Published: (2024-09-01)

Advances in the Development of SARS-CoV-2 Mpro Inhibitors
by: Laura Agost-Beltrán, et al.
Published: (2022-04-01)

Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents
by: Agnieszka Zagórska, et al.
Published: (2024-07-01)

In silico exploration of Lycoris alkaloids as potential inhibitors of SARS-CoV-2 main protease (Mpro)
by: Fredrick Mutie Musila, et al.
Published: (2022-09-01)

Identification of potential antiviral lead inhibitors against SARS-CoV-2 main protease: Structure-guided virtual screening, docking, ADME, and MD Simulation based approach
by: Goverdhan Lanka, et al.
Published: (2023-12-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
by: Camilla Isgrò, et al.
Published: (2021-01-01)

Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents
by: Alzyoud L, et al.
Published: (2022-08-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
by: Ísis Venturi Biembengut, et al.

Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
by: Mohamed Elagawany, et al.
Published: (2022-12-01)

Computational Insights into Acrylamide Fragment Inhibition of SARS-CoV-2 Main Protease
by: Ping Chen, et al.
Published: (2024-11-01)

The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
by: Mateus Sá Magalhães Serafim, et al.
Published: (2023-07-01)

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
by: Soumya Gulab Katre, et al.
Published: (2022-06-01)

In silico binding role of flavonoids as SARS-CoV-2 main protease (Mpro) inhibitors: A dataset of molecular docking simulation-based high-throughput virtual screening (HTVS)Mendeley Data
by: Mariyam Eema, et al.
Published: (2025-04-01)

Identification of 1H-purine-2,6-dione derivative as a potential SARS-CoV-2 main protease inhibitor: molecular docking, dynamic simulations, and energy calculations
by: Hossam Nada, et al.
Published: (2022-10-01)

An in-silico Evaluation of Some Schiff bases for Their Potency Against SARS-CoV-2 Main Protease, PASS Prediction and ADMET Studies
by: Mohammad Nasir Uddin, et al.
Published: (2023-04-01)

Molecular Docking and Simulation-Binding Analysis of Plant Phytochemicals with the Hepatocellular Carcinoma Targets Epidermal Growth Factor Receptor and Caspase-9
by: Ghulam Mustafa, et al.
Published: (2023-04-01)

Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid
by: Jonathan T. Lee, et al.
Published: (2022-08-01)